Evidence map›Paper›PMID 26189493›Full record

ArticleBMC medical genetics2015

First de novo KCND3 mutation causes severe Kv4.3 channel dysfunction leading to early onset cerebellar ataxia, intellectual disability, oral apraxia and epilepsy.

Katrien Smets, Anna Duarri, Tine Deconinck, Berten Ceulemans, Bart P van de Warrenburg, Stephan Züchner, Michael Anthony Gonzalez, Rebecca Schüle, Matthis Synofzik, Nathalie Van der Aa and 3 more

Open access · goldAbstract readCase Reports
In one paragraph

Article in BMC medical genetics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 1 pooled it
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 1 synthesis or guideline pooled it, 67 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Review
  6. Restoration of Shal/KCellular and molecular life sciences : CMLS · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. An E280K Missense Variant inInternational journal of molecular sciences · 2023
    Article
  14. Article
  15. Virtual/Remote Labs for Fluorescent Immunocytochemistry or Western Blotting: The Next Best Thing to Being There.Journal of undergraduate neuroscience education : JUNE : a publication of FUN, Faculty for Undergraduate Neuroscience · 2022
    Article
  16. Article
  17. Rare Gain-of-FunctionInternational journal of molecular sciences · 2021
    Article
  18. NovelInternational journal of molecular sciences · 2021
    Article
  19. Article
  20. Variation of Two S3b Residues in KFrontiers in pharmacology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 7 institutions in 4 countries.

Katrien SmetsNeurogenetics Group, VIB-Department of Molecular Genetics, University of Antwerp, Campus Drie Eiken, Universiteitsplein 1, 2610, Antwerp, Belgium. katrien.smets@uza.be.
Anna DuarriDepartment of Genetics, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands. a.duarri@umcg.nl.
Tine DeconinckNeurogenetics Group, VIB-Department of Molecular Genetics, University of Antwerp, Campus Drie Eiken, Universiteitsplein 1, 2610, Antwerp, Belgium. tine.deconinck@molgen.vib-ua.be.
Berten CeulemansDepartment of Neurology, Antwerp University Hospital, Antwerp, Belgium. berten.ceulemans@uza.be.
Bart P van de WarrenburgDepartment of Neurology, Donders Institute of Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands. Bart.vandeWarrenburg@radboudumc.nl.
Stephan ZüchnerDepartment of Human Genetics and Hussman Institute for Human Genomics, Miller School of Medicine, University of Miami, Miami, USA. SZuchner@med.miami.edu.
Michael Anthony GonzalezDepartment of Human Genetics and Hussman Institute for Human Genomics, Miller School of Medicine, University of Miami, Miami, USA. MGonzalez15@med.miami.edu.
Rebecca SchüleDepartment of Human Genetics and Hussman Institute for Human Genomics, Miller School of Medicine, University of Miami, Miami, USA. rebecca.schuele-freyer@uni-tuebingen.de.
Matthis SynofzikHertie-Institute for Clinical Brain Research, Department of Neurodegenerative Diseases, University of Tübingen, Tübingen, Germany. matthis.synofzik@uni-tuebingen.de.
Nathalie Van der AaPediatrics Outpatient Clinic, Edegem, Antwerp, Belgium. nathalie.van.der.aa1@telenet.be.
Peter De JongheNeurogenetics Group, VIB-Department of Molecular Genetics, University of Antwerp, Campus Drie Eiken, Universiteitsplein 1, 2610, Antwerp, Belgium. peter.dejonghe@molgen.vib-ua.be.
Dineke S VerbeekDepartment of Genetics, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands. d.s.verbeek@umcg.nl.
Jonathan BaetsNeurogenetics Group, VIB-Department of Molecular Genetics, University of Antwerp, Campus Drie Eiken, Universiteitsplein 1, 2610, Antwerp, Belgium. jonathan.baets@molgen.vib-ua.be.
University of Miami · USUniversity Medical Center Groningen · NLUniversity of Antwerp · BEVIB-UAntwerp Center for Molecular Neurology · BEAntwerp University Hospital · BEHertie Institute for Clinical Brain Research · DERadboud University Nijmegen · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIdentification of the first de novo mutation in potassium voltage-gated channel, shal-related subfamily, member 3 (KCND3) in a patient with complex early onset cerebellar ataxia in order to expand the genetic and phenotypic spectrum.

methodsWhole exome sequencing in a cerebellar ataxia patient and subsequent immunocytochemistry, immunoblotting and patch clamp assays of the channel were performed.

resultsA de novo KCND3 mutation (c.877_885dupCGCGTCTTC; p.Arg293_Phe295dup) was found duplicating the RVF motif and thereby adding an extra positive charge to voltage-gated potassium 4.3 (Kv4.3) in the voltage-sensor domain causing a severe shift of the voltage-dependence gating to more depolarized voltages. The patient displayed a severe phenotype with early onset cerebellar ataxia complicated by intellectual disability, epilepsy, attention deficit hyperactivity disorder, strabismus, oral apraxia and joint hyperlaxity.

conclusionsWe identified a de novo KCND3 mutation causing the most marked change in Kv4.3's channel properties reported so far, which correlated with a severe and unique spinocerebellar ataxia (SCA) type 19/22 disease phenotype.

Indexed as

ApraxiasBase SequenceCell Line, TumorChildEpilepsyGenetic MarkersHeLa CellsHumansIntellectual DisabilityMalePatch-Clamp TechniquesSequence Analysis, DNAShal Potassium ChannelsSpinocerebellar DegenerationsGenetic MarkersKCND3 protein, humanShal Potassium Channels

Identifiers

PMID26189493
PMCPMC4557545
OpenAlexW1549941807

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.